TRAIL and TRAIL receptors splice variants during long-term interferon β treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response

OBJECTIVE: We aimed to assess the effects of interferon β (IFNβ) treatment on the expression of the splice variants of the Tumour necrosis factor-Related Apoptosis Inducing Ligand (TRAIL) and its receptors in different cell subpopulations (CD14+, CD4+ and CD8+) from patients with multiple sclerosis...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Gómez, Carlos, Oliver-Martos, Begoña, Pinto-Medel, María-Jesús, Suardiaz, Margarita, Reyes-Garrido, Virginia, Urbaneja, Patricia, Fernández, Óscar, Leyva, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752633/
https://www.ncbi.nlm.nih.gov/pubmed/25736057
http://dx.doi.org/10.1136/jnnp-2014-309932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752633/
https://www.ncbi.nlm.nih.gov/pubmed/25736057
http://dx.doi.org/10.1136/jnnp-2014-309932

Ejemplares similares